Keywords: enzon, oncaspar, approved, usa, pegaspargase, been, treatment
ENZON'S ONCASPAR APPROVED IN USA
Article | 14 February 1994
Enzon's Oncaspar (pegaspargase) has been approved for the treatment of patients with acute lymphoblastic leukemia "who require L-asparaginase in their ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
